The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Survival outcomes for right- versus left-sided colon cancer and rectal cancer in patients receiving regorafenib and/or trifluridine/tipiracil for refractory metastatic colorectal cancer: Findings from the multicenter retrospective ReTrITa study.
 
Carlo Signorelli
Honoraria - Bayer
Consulting or Advisory Role - Amgen
Travel, Accommodations, Expenses - Bayer
 
Maria Alessandra Calegari
Honoraria - Amgen; Merck; Pierre Fabre; SERVIER
Consulting or Advisory Role - Merck
Travel, Accommodations, Expenses - Merck; Pierre Fabre; SERVIER
 
Alessandro Passardi
No Relationships to Disclose
 
Jessica Lucchetti
No Relationships to Disclose
 
Ina Valeria Zurlo
No Relationships to Disclose
 
Cristina Morelli
No Relationships to Disclose
 
Emanuela Dell'Aquila
No Relationships to Disclose
 
Donatello Gemma
No Relationships to Disclose
 
Alessandra Emiliani
No Relationships to Disclose
 
Giulia Arrivi
No Relationships to Disclose
 
Federica Zoratto
No Relationships to Disclose
 
Mario Giovanni Chilelli
No Relationships to Disclose
 
Maria Grazia Morandi
No Relationships to Disclose
 
Fiorenza Santamaria
No Relationships to Disclose
 
Manuela Dettori
No Relationships to Disclose
 
Antonella Cosimati
No Relationships to Disclose
 
Rosa Saltarelli
No Relationships to Disclose
 
Alessandro Minelli
No Relationships to Disclose
 
Emanuela Lucci-Cordisco
Honoraria - AstraZeneca; GlaxoSmithKline; MSD
 
Michele Basso
No Relationships to Disclose